Live Breaking News & Updates on Adjuvant Alectinib

Stay updated with breaking news from Adjuvant alectinib. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Donington and Stiles Describe the Surgical Implications of Lung Cancer Treatment Evolutions

Drs Donington and Stiles discuss how the findings from the ADAURA trial with adjuvant osimertinib have changed thoracic surgery expectations, the potential surgical implications of the ALINA trial with adjuvant alectinib, and the importance of early-stage molecular testing in lung cancer. ....

United States , New York , University Of Chicago , Caroline Seymour , Brendonm Stiles , Jessicas Donington , Department Of Cardiothoracic Vascular Surgery , Department Of Surgery , Department Of Medicine Oncology Hematology , Department Of Oncology Medical , Live On Air , Thoracic Surgery , Surgical Oncology , Montefiore Einstein Comprehensive Cancer Center , Vascular Surgery , Medical Oncology , Drs Donington , Onclive On Air , Apple Podcasts , Google Podcasts , Amazon Music , Adaura Trial , Padjuvant Osimertinib , Alina Trial , Adjuvant Alectinib , Early Stage Molecular Testing In Lung Cance ,

ALINA: Efficacy and Safety of Adjuvant Alectinib Versus Chemotherapy in Patients With Early-Stage ALK+ NSCLC

Benjamin Solomon, MBBS, PhD, FRACP, presents key data from the ALINA study investigating alectinib versus chemotherapy as adjuvant therapy in patients with stage IB–IIIA anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC). ....

Patients With Early Stage , Lung Cancer , Non Small Cell Lung Cancer , Alina Trial , Alina Study , Adjuvant Alectinib , Dr Benjamin Solomon , Early Stage Alk Nsclc ,

ESMO 2023: Experts Preview Anticipated Data Spanning Tumor Types

The 2023 ESMO Congress, which is taking place in Madrid, Spain, and will continue to be accessible online via a virtual platform, is gearing up to kick off, and the oncology community is ready to learn more about the latest data across malignancies. ....

United States , Ibiayi Dagogo Jack , Kishor Ganti , Novartis Pluvicto , Pembrolizumab Keytruda , Heather Mcarthur , Daiichi Sankyo , Balazs Halmos , Genentech Alecensa , Heather Wakelee , Jeffreys Weber , Dagogo Jack , Christopherk Glanz , Perlmutter Cancer Center , Bladder Cancer Research , Melanoma Research Program , Department Of Internal Medicine , Division Of Oncology Hematology , Harvard Medical School , Pamela Buffett Cancer Center , Drug Administration , Adventhealth Cancer Institute , Breast Cancer Program At Simmons Center , Department Of Oncology , Ut Southwestern Medical Center , Clinical Research Unit ,